Works matching AU Sarli, Vasiliki
Results: 18
Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes in a Cell-Free Assay.
- Published in:
- Biomedicines, 2021, v. 9, n. 8, p. 1028, doi. 10.3390/biomedicines9081028
- By:
- Publication type:
- Article
Inhibitors of Mitotic Kinesins: Next-Generation Antimitotics.
- Published in:
- ChemMedChem, 2006, v. 1, n. 3, p. 293, doi. 10.1002/cmdc.200500045
- By:
- Publication type:
- Article
Cover Picture: Synthesis of Cyclopamine Using a Biomimetic and Diastereoselective Approach (Angew. Chem. Int. Ed. 42/2009).
- Published in:
- Angewandte Chemie International Edition, 2009, v. 48, n. 42, p. 7707, doi. 10.1002/anie.200904019
- By:
- Publication type:
- Article
Synthesis of Cyclopamine Using a Biomimetic and Diastereoselective Approach.
- Published in:
- Angewandte Chemie International Edition, 2009, v. 48, n. 42, p. 7911, doi. 10.1002/anie.200902520
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Novel Eg5 Inhibitors.
- Published in:
- ChemBioChem, 2005, v. 6, n. 11, p. 2005, doi. 10.1002/cbic.200500168
- By:
- Publication type:
- Article
Synthesis and Cytotoxic Effects of 3,6‐Bis‐indolyl 2,5‐Dihydroxybenzoquinone Acetates.
- Published in:
- ChemistrySelect, 2022, v. 7, n. 32, p. 1, doi. 10.1002/slct.202202060
- By:
- Publication type:
- Article
Aza-Reversine Promotes Reprogramming of Lung (MRC-5) and Differentiation of Mesenchymal Cells into Osteoblasts.
- Published in:
- Materials (1996-1944), 2021, v. 14, n. 18, p. 5385, doi. 10.3390/ma14185385
- By:
- Publication type:
- Article
Targeting on poly(ADP-ribose) polymerase activity with DNA-damaging hybrid lactam-steroid alkylators in wild-type and BRCA1-mutated ovarian cancer cells.
- Published in:
- Chemical Biology & Drug Design, 2017, v. 90, n. 5, p. 854, doi. 10.1111/cbdd.13006
- By:
- Publication type:
- Article
3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 7369, doi. 10.2147/OTT.S254856
- By:
- Publication type:
- Article
Indeno[1,2- d]pyrido[1,2- a]pyrimidines: A New Class of Receptor Tyrosine Kinase Inhibitors.
- Published in:
- ChemMedChem, 2008, v. 3, n. 3, p. 429, doi. 10.1002/cmdc.200700306
- By:
- Publication type:
- Article
Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents.
- Published in:
- Molecules, 2022, v. 27, n. 19, p. 6632, doi. 10.3390/molecules27196632
- By:
- Publication type:
- Article
Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-38217-8
- By:
- Publication type:
- Article
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 381, doi. 10.3390/pharmaceutics15020381
- By:
- Publication type:
- Article
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 6, p. 885, doi. 10.3390/pharmaceutics13060885
- By:
- Publication type:
- Article
Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 493, doi. 10.3390/pharmaceutics13040493
- By:
- Publication type:
- Article
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1263, doi. 10.3390/cancers12051263
- By:
- Publication type:
- Article
Editorial: Protein kinase inhibitors in neurodegeneration and cancer targeted therapies.
- Published in:
- Frontiers in Cell & Developmental Biology, 2024, p. 01, doi. 10.3389/fcell.2024.1413293
- By:
- Publication type:
- Article